CEACAMP11

Across TCGA pan-cancer cohorts, CEACAMP11 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of CEACAMP11’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where CEACAMP11 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CEACAMP11 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

HNSC, KIRC, and LUSC are the cancer types where CEACAMP11 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CEACAMP11 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.061	.002	6	view →
KIRC	All	All	−0.032	.004	4	view →
LUSC	Female	All	+0.120	.001	3	view →
LIHC	All	All	+0.043	.006	3	view →
KICH	All	All	+0.155	.029	2	view →
THCA	All	II,III,IV	+0.103	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

CEACAMP11–HNSC

Open the HNSC breakdown →